[Translation] A Phase I, open-label, multicenter study to evaluate the safety, tolerability, PK and efficacy of MK-1084 as monotherapy and in combination in subjects with KRASG12C mutated advanced solid tumors
主要目的为确定MK-1084在单药治疗和联合治疗时的安全性和耐受性
[Translation] The primary purpose is to determine the safety and tolerability of MK-1084 in monotherapy and combination therapy